FDA warning letters
A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.
686 letters match. Newest first.
-
DrugsMONQ, LLC
MONQ sold unapproved inhalation essential oil products with claims to treat opioid addiction and withdrawal, FDA and FTC said.
High risk -
DrugsIndustrias Cklass S. de R.L. de C.V.
FDA found Industrias Cklass hand sanitizer labeled 70% ethanol contained 19% ethanol and 48% methanol and was refused U.S. admission.
High risk -
DrugsMonarch PCM, LLC
Monarch PCM, LLC made unapproved skin drugs and broke manufacturing rules, with microbial contamination and weak investigations.
High risk -
FoodGolden Lab LLC
Golden Lab sold eye and allergy capsules with unapproved drug claims and lacked required supplement manufacturing controls.
High risk -
FoodDLG Naturals, Inc.
DLG Naturals sold shea butter, seed oils, and Kigelia extract as unapproved new drugs (not FDA-approved) with disease-treatment claims on its website.
Medium -
DrugsHybrid Pharma, LLC
FDA warned outsourcing facility Hybrid Pharma of Deerfield Beach, Florida, that sterile compounding violations made its drugs adulterated and unapproved.
High risk -
DrugsAire-Master of America, Inc.
FDA cites Aire-Master of America for CGMP failures and unapproved, misbranded hand sanitizers made at its Missouri plant.
High risk -
FoodCAJ Food Products Inc.
CAJ Food Products marketed Biotta and Juice Performer juices with disease claims, making them unapproved new drugs, FDA says.
High risk -
AnimalHope Botanicals, LLC
FDA warned Hope Botanicals that its CBD products for animals and humans are unapproved drugs and its raspberry gummies contain an unsafe food additive.
High risk -
AnimalPlantacea, LLC dba Kahm
FDA warned Plantacea, doing business as Kahm, about unapproved CBD drugs for humans and animals and adulterated CBD gummies.
High risk -
AnimalHaniel Concepts, Inc. DBA Free State Oils, LLC
FDA warned Free State Oils over website claims that its CBD products treat disease, including COVID-19, and are unapproved drugs and adulterated foods.
High risk -
DrugsAyuryoga, Inc.
FDA warned Ayuryoga/Kottakkal Ayurveda USA that its ayurvedic products are unapproved new drugs promoted with disease-treatment claims online.
High risk -
DrugsSanthigram Kerala Ayurvedic Co. of U.S., Inc.
FDA told Santhigram Kerala Ayurvedic Co. of U.S. that its ayurvedic products are unapproved new drugs sold with disease claims online.
High risk -
FoodSunny Creek Farm, Inc.
Sunny Creek Farm sold sprouts from pathogen-positive seed lots and made unapproved disease-treatment claims.
High risk -
DrugsInhousepharmacy.vu
Vanuatu online pharmacy Inhousepharmacy.vu sold unapproved domperidone to US consumers over the internet.
High risk -
FoodIronmag Labs
FDA warned Ironmag Labs that its CBD Gummies and stimulant supplements are adulterated (illegal because unsafe/missing filings) and unapproved new drugs.
High risk -
DrugsDelta 8 Hemp
FDA warned Delta 8 Hemp over unapproved Delta-8 THC drugs and adulterated gummies sold online.
High risk -
DrugsATLRx, Inc.
FDA warned ATLRx that its CBD and Delta-8 THC products are unapproved drugs with illegal disease claims.
High risk -
DrugsKingdom Harvest
Kingdom Harvest marketed CBD and Delta-8 THC products with unapproved drug claims and unsafe food and animal drug uses.
High risk -
DrugsBioMD Plus LLC
FDA warned BioMD Plus LLC that its CBD and Delta-8 THC products are unapproved drugs and its Delta-8 gummies contain an unsafe food additive.
High risk -
DrugsM Six Labs, Inc.
FDA warned M Six Labs over unapproved CBD/Delta-8 THC drugs, illegal CBD/Delta-8 foods, and animal drugs sold online.
High risk -
FoodC R Supplements, LLC
FDA warned C R Supplements that its mineral supplements were sold as unapproved new drugs and made without required quality controls.
High risk -
FoodMYA International, Inc.
FDA warned MYA International that its supplement and herbal product labels made unapproved drug claims and its dietary supplements violated manufacturing quality and labeling rules.
High risk -
FoodRena's Organic
U.S. Food and Drug Administration (FDA) warned Rena's Organic over unapproved CBD drug claims for tinctures, creams, foods, and pet product.
High risk -
DrugsGuangzhou Zhongkebaishi Health Industry Co., Ltd.
Guangzhou Zhongkebaishi's Hand Sanitizer Gel, labeled 75% ethanol, tested at 51% and was refused US import.
High risk -
DrugsClinical Resolution Laboratory Inc.
FDA warned Clinical Resolution Laboratory in Brea, CA, about CGMP failures and unapproved OTC drugs.
High risk -
DrugsKleenhanz, LLC
FDA told Kleenhanz its antiseptic towelettes were unapproved drugs because the website and Twitter claimed they fight COVID-19 and other diseases.
High risk -
DrugsElements Brands Inc.
FDA warned Elements Brands that its eb5 Skin Lightening Cream is an unapproved, misbranded new drug.
High risk -
DrugsUltimark Products
Ultimark Products sells Porcelana Day Skin Lightening Cream, an unapproved and misbranded hydroquinone skin-bleaching drug, FDA says.
High risk -
DrugsSkinPro
SkinPro sells an unapproved, misbranded hydroquinone skin-bleaching drug without FDA approval.
High risk -
DrugsSkin PS Brands
FDA warns Skin PS Brands that Dark Spot Fix, a hydroquinone skin-lightening drug, is an unapproved and misbranded new drug.
High risk -
DrugsClinical Formula LLC
FDA warned Clinical Formula LLC that its Clinical Formula Bleaching Lotion is an unapproved and misbranded skin-lightening drug.
Medium -
DrugsNeoteric Cosmetics, Incorporated/Scott’s Liquid Gold, Inc.
FDA warned Neoteric Cosmetics and parent Scott's Liquid Gold that ALPHA Skin Care Dual Action Fade Cream, a hydroquinone skin lightener, is an unapproved and misbranded drug.
Medium -
DrugsDr. Thomas Balshi/Intilight
FDA warned Dr. Thomas Balshi/Intilight that its hydroquinone skin-lightening cream is an unapproved and misbranded new drug.
High risk -
DrugsSkin Authority, L.L.C.
FDA warns Skin Authority that its skinauthority Hyperpigmentation Treatment is an unapproved and misbranded skin-bleaching drug.
High risk -
DrugsAMBI Enterprises LLC
AMBI sold two unapproved hydroquinone skin-bleaching fade creams with unlawful labeling, FDA says.
High risk -
DrugsGenomma Lab USA, Inc.
Genomma Lab USA sold two hydroquinone skin-lightening creams as unapproved and misbranded new drugs, FDA says.
High risk -
DrugsM & M Beauty and Wellness, LLC
FDA says M & M Beauty and Wellness sells an unapproved, misbranded hydroquinone skin-lightening cream.
High risk -
DrugsTrue Earth Health Products, LLC
FDA warned True Earth Health Products over Plexaderm Dark Spot Fade Gel, an unapproved, misbranded hydroquinone skin-bleaching drug.
High risk -
Drugswww.wellerectile.com
FDA warned India-based www.wellerectile.com over selling unapproved, improperly labeled drugs online, including hydroxychloroquine claimed to treat COVID-19.
High risk -
DrugsGeneritech Corporation
FDA warned Generitech Corporation of Fresno, California over CGMP failures in its topical drug manufacturing and unapproved hydroquinone skin bleaching creams.
High risk -
DrugsCofixRx, LLC
FDA warned CofixRx that its CofixRX Nasal Spray is an unapproved, misbranded drug sold with COVID-19 prevention claims.
High risk -
DrugsSensory Cloud, Inc
FDA and FTC warn Sensory Cloud that its FEND nasal mister is an unapproved, misbranded drug sold with COVID-19 prevention and treatment claims.
High risk -
DrugsNDAL Mfg Inc.
NDAL Mfg's honey nasal sprays had manufacturing-rule violations, microbial contamination, and lacked FDA approval as new drugs.
High risk -
FoodHoney Feast, Inc.
Honey Feast, Inc. sold honey products online with disease-treatment claims, making them unapproved new drugs and misbranded.
Low -
DrugsCBD Social
FDA and FTC warn CBD Social over website claims that CBD products prevent or treat COVID-19.
High risk -
DrugsFunctional Remedies, LLC D/B/A Synchronicity Hemp Oil
FDA and FTC told a Louisville, Colorado hemp and CBD seller that its website claims the products treat or prevent COVID-19, making them unapproved and misbranded drugs.
High risk -
DrugsCureganics
Cureganics sold CBD products with website claims they prevent or treat COVID-19, making them unapproved and misbranded drugs.
High risk -
DrugsNature's Highway
FDA and FTC warned CBD seller Nature's Highway for selling unapproved drugs claimed to treat or prevent COVID-19.
High risk -
DrugsUPSY LLC
FDA and FTC warned UPSY LLC that its website sells CBD products claimed to treat or prevent COVID-19 as unapproved, misbranded drugs.
High risk